Mutations in the p53 gene occur in diverse human tumour types - PubMed (original) (raw)
. 1989 Dec 7;342(6250):705-8.
doi: 10.1038/342705a0.
Affiliations
- PMID: 2531845
- DOI: 10.1038/342705a0
Free article
Mutations in the p53 gene occur in diverse human tumour types
J M Nigro et al. Nature. 1989.
Free article
Abstract
The p53 gene has been a constant source of fascination since its discovery nearly a decade ago. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes. Moreover, in human tumours, the short arm of chromosome 17 is often deleted. In colorectal cancers, the smallest common region of deletion is centred at 17p13.1; this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.
Similar articles
- p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M, et al. Matozaki T, et al. Cancer Res. 1992 Aug 15;52(16):4335-41. Cancer Res. 1992. PMID: 1322785 - p53 gene mutations in colorectal tumors from patients with familial polyposis coli.
Shirasawa S, Urabe K, Yanagawa Y, Toshitani K, Iwama T, Sasazuki T. Shirasawa S, et al. Cancer Res. 1991 Jun 1;51(11):2874-8. Cancer Res. 1991. PMID: 1851662 - Expression of p53 and 17p allelic loss in colorectal carcinoma.
Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN. Cunningham J, et al. Cancer Res. 1992 Apr 1;52(7):1974-80. Cancer Res. 1992. PMID: 1551126 - Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
Pollock PM, Pearson JV, Hayward NK. Pollock PM, et al. Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review. - Tumor suppressor genes.
Levine AJ. Levine AJ. Bioessays. 1990 Feb;12(2):60-6. doi: 10.1002/bies.950120203. Bioessays. 1990. PMID: 2140509 Review.
Cited by
- Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4.
Polotskaia A, Xiao G, Reynoso K, Martin C, Qiu WG, Hendrickson RC, Bargonetti J. Polotskaia A, et al. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1220-9. doi: 10.1073/pnas.1416318112. Epub 2015 Mar 2. Proc Natl Acad Sci U S A. 2015. PMID: 25733866 Free PMC article. - Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN. Khosla S, et al. J Clin Invest. 1991 May;87(5):1691-9. doi: 10.1172/JCI115186. J Clin Invest. 1991. PMID: 2022740 Free PMC article. - Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Shaw P, et al. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9. doi: 10.1073/pnas.89.10.4495. Proc Natl Acad Sci U S A. 1992. PMID: 1584781 Free PMC article. - Somatic TP53 Mutations in the Era of Genome Sequencing.
Hainaut P, Pfeifer GP. Hainaut P, et al. Cold Spring Harb Perspect Med. 2016 Nov 1;6(11):a026179. doi: 10.1101/cshperspect.a026179. Cold Spring Harb Perspect Med. 2016. PMID: 27503997 Free PMC article. Review. - A machine learning and directed network optimization approach to uncover TP53 regulatory patterns.
Triantafyllidis CP, Barberis A, Hartley F, Cuervo AM, Gjerga E, Charlton P, van Bijsterveldt L, Rodriguez JS, Buffa FM. Triantafyllidis CP, et al. iScience. 2023 Oct 26;26(12):108291. doi: 10.1016/j.isci.2023.108291. eCollection 2023 Dec 15. iScience. 2023. PMID: 38047081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous